nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00339	0.00339	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00331	0.00331	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.00329	0.00329	CbGpPWpGaD
Raloxifene—AOX1—Disease—MAML3—salivary gland cancer	0.00319	0.00319	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00317	0.00317	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00316	0.00316	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MAML3—salivary gland cancer	0.00316	0.00316	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—FOXO3—salivary gland cancer	0.00316	0.00316	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—MARCKS—salivary gland cancer	0.00315	0.00315	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—UHRF1—salivary gland cancer	0.00303	0.00303	CbGpPWpGaD
Raloxifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—salivary gland cancer	0.00302	0.00302	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—CCND1—salivary gland cancer	0.00302	0.00302	CbGpPWpGaD
Raloxifene—EBP—Metabolism—NUP62—salivary gland cancer	0.00298	0.00298	CbGpPWpGaD
Raloxifene—EBP—Metabolism—VCAN—salivary gland cancer	0.00296	0.00296	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PYGB—salivary gland cancer	0.00292	0.00292	CbGpPWpGaD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—salivary gland cancer	0.00283	0.00283	CbGpPWpGaD
Raloxifene—ESR1—ATF-2 transcription factor network—EP300—salivary gland cancer	0.00278	0.00278	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—salivary gland cancer	0.00275	0.00275	CbGpPWpGaD
Raloxifene—AOX1—Disease—ST3GAL4—salivary gland cancer	0.00274	0.00274	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00272	0.00272	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—CCND1—salivary gland cancer	0.0027	0.0027	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—CCND1—salivary gland cancer	0.00263	0.00263	CbGpPWpGaD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—EP300—salivary gland cancer	0.0026	0.0026	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.0026	0.0026	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—MAP2K2—salivary gland cancer	0.00258	0.00258	CbGpPWpGaD
Raloxifene—ESR1—LKB1 signaling events—TP53—salivary gland cancer	0.00256	0.00256	CbGpPWpGaD
Raloxifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—salivary gland cancer	0.00255	0.00255	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—PTEN—salivary gland cancer	0.00254	0.00254	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.00253	0.00253	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—CCND1—salivary gland cancer	0.00249	0.00249	CbGpPWpGaD
Raloxifene—AOX1—Disease—DTX4—salivary gland cancer	0.00249	0.00249	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.00247	0.00247	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—EP300—salivary gland cancer	0.00242	0.00242	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PHGDH—salivary gland cancer	0.00238	0.00238	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K2—salivary gland cancer	0.00234	0.00234	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.00234	0.00234	CbGpPWpGaD
Raloxifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.00232	0.00232	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00231	0.00231	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NFIB—salivary gland cancer	0.0023	0.0023	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—ARID4B—salivary gland cancer	0.0023	0.0023	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ST3GAL4—salivary gland cancer	0.00229	0.00229	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—MC3R—salivary gland cancer	0.00226	0.00226	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.00226	0.00226	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.00221	0.00221	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.00216	0.00216	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00215	0.00215	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.00213	0.00213	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00211	0.00211	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—AQP1—salivary gland cancer	0.00208	0.00208	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—MC3R—salivary gland cancer	0.00206	0.00206	CbGpPWpGaD
Raloxifene—AOX1—Disease—FGF16—salivary gland cancer	0.00206	0.00206	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MC3R—salivary gland cancer	0.00205	0.00205	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ISYNA1—salivary gland cancer	0.002	0.002	CbGpPWpGaD
Raloxifene—AOX1—Disease—NUP62—salivary gland cancer	0.00197	0.00197	CbGpPWpGaD
Raloxifene—AOX1—Disease—VCAN—salivary gland cancer	0.00196	0.00196	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NUP62—salivary gland cancer	0.00195	0.00195	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.00191	0.00191	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MC3R—salivary gland cancer	0.00188	0.00188	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.00185	0.00185	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MAML2—salivary gland cancer	0.00185	0.00185	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.00184	0.00184	CbGpPWpGaD
Raloxifene—AOX1—Disease—MAML2—salivary gland cancer	0.00179	0.00179	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.00177	0.00177	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MAML2—salivary gland cancer	0.00177	0.00177	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00176	0.00176	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—salivary gland cancer	0.00174	0.00174	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.00173	0.00173	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—NUP62—salivary gland cancer	0.00165	0.00165	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—VCAN—salivary gland cancer	0.00164	0.00164	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—SMC1A—salivary gland cancer	0.00163	0.00163	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MARCKS—salivary gland cancer	0.00163	0.00163	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00159	0.00159	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00159	0.00159	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MAML3—salivary gland cancer	0.00159	0.00159	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.00159	0.00159	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.00157	0.00157	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—HRAS—salivary gland cancer	0.00157	0.00157	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.00154	0.00154	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—WNT5B—salivary gland cancer	0.00154	0.00154	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.00154	0.00154	CbGpPWpGaD
Raloxifene—AOX1—Disease—JAG1—salivary gland cancer	0.00153	0.00153	CbGpPWpGaD
Raloxifene—AOX1—Disease—FGFR4—salivary gland cancer	0.00152	0.00152	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PYGB—salivary gland cancer	0.00151	0.00151	CbGpPWpGaD
Raloxifene—AOX1—Disease—FBXW7—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL17RD—salivary gland cancer	0.00149	0.00149	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.00146	0.00146	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.00142	0.00142	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—WNT5B—salivary gland cancer	0.00141	0.00141	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PTEN—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAML3—salivary gland cancer	0.00136	0.00136	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL17RD—salivary gland cancer	0.00136	0.00136	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.00131	0.00131	CbGpPWpGaD
Raloxifene—EBP—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.00131	0.00131	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ISYNA1—salivary gland cancer	0.00128	0.00128	CbGpPWpGaD
Raloxifene—AOX1—Disease—FOXO3—salivary gland cancer	0.00126	0.00126	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAML3—salivary gland cancer	0.00124	0.00124	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PHGDH—salivary gland cancer	0.00123	0.00123	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MC3R—salivary gland cancer	0.00121	0.00121	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ST3GAL4—salivary gland cancer	0.00119	0.00119	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.00118	0.00118	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—WNT5B—salivary gland cancer	0.00117	0.00117	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00117	0.00117	CbGpPWpGaD
Raloxifene—EBP—Metabolism—CREBBP—salivary gland cancer	0.00116	0.00116	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.00114	0.00114	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL17RD—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MC3R—salivary gland cancer	0.00111	0.00111	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00109	0.00109	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ISYNA1—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—AQP1—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00107	0.00107	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DTX4—salivary gland cancer	0.00106	0.00106	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.00105	0.00105	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MARCKS—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAML3—salivary gland cancer	0.00104	0.00104	CbGpPWpGaD
Raloxifene—AOX1—Disease—MAP2K2—salivary gland cancer	0.00103	0.00103	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NUP62—salivary gland cancer	0.000984	0.000984	CbGpPWpGaD
Raloxifene—HTR2B—G alpha (q) signalling events—PIK3CA—salivary gland cancer	0.000981	0.000981	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PYGB—salivary gland cancer	0.000971	0.000971	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DTX4—salivary gland cancer	0.000968	0.000968	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.000965	0.000965	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000938	0.000938	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MC3R—salivary gland cancer	0.000923	0.000923	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—HRAS—salivary gland cancer	0.000892	0.000892	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MAML2—salivary gland cancer	0.000891	0.000891	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000888	0.000888	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MARCKS—salivary gland cancer	0.000884	0.000884	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	0.000877	0.000877	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGF16—salivary gland cancer	0.000877	0.000877	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000874	0.000874	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NUP62—salivary gland cancer	0.000854	0.000854	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—VCAN—salivary gland cancer	0.000848	0.000848	CbGpPWpGaD
Raloxifene—AOX1—Disease—NOTCH1—salivary gland cancer	0.000844	0.000844	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NOTCH1—salivary gland cancer	0.000834	0.000834	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PTEN—salivary gland cancer	0.000826	0.000826	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SMC1A—salivary gland cancer	0.000823	0.000823	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PYGB—salivary gland cancer	0.000822	0.000822	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	0.000812	0.000812	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DTX4—salivary gland cancer	0.000807	0.000807	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000804	0.000804	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGF16—salivary gland cancer	0.000801	0.000801	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000792	0.000792	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PHGDH—salivary gland cancer	0.000792	0.000792	CbGpPWpGaD
Raloxifene—EBP—Metabolism—EP300—salivary gland cancer	0.000787	0.000787	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000777	0.000777	CbGpPWpGaD
Raloxifene—AOX1—Disease—CREBBP—salivary gland cancer	0.000765	0.000765	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAML2—salivary gland cancer	0.000762	0.000762	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ST3GAL4—salivary gland cancer	0.000762	0.000762	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—CREBBP—salivary gland cancer	0.000756	0.000756	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000744	0.000744	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000743	0.000743	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAML2—salivary gland cancer	0.000696	0.000696	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—AQP1—salivary gland cancer	0.000692	0.000692	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—MAP2K2—salivary gland cancer	0.000678	0.000678	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PHGDH—salivary gland cancer	0.00067	0.00067	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGF16—salivary gland cancer	0.000667	0.000667	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—JAG1—salivary gland cancer	0.000651	0.000651	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGFR4—salivary gland cancer	0.000648	0.000648	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ST3GAL4—salivary gland cancer	0.000645	0.000645	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CREBBP—salivary gland cancer	0.000641	0.000641	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FBXW7—salivary gland cancer	0.000637	0.000637	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—JAG1—salivary gland cancer	0.000594	0.000594	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGFR4—salivary gland cancer	0.000591	0.000591	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—AQP1—salivary gland cancer	0.000586	0.000586	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PIK3CA—salivary gland cancer	0.000582	0.000582	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000582	0.000582	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FBXW7—salivary gland cancer	0.000582	0.000582	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAML2—salivary gland cancer	0.000579	0.000579	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NUP62—salivary gland cancer	0.000549	0.000549	CbGpPWpGaD
Raloxifene—AOX1—Disease—PTEN—salivary gland cancer	0.000546	0.000546	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—VCAN—salivary gland cancer	0.000544	0.000544	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FOXO3—salivary gland cancer	0.000538	0.000538	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000531	0.000531	CbGpPWpGaD
Raloxifene—AOX1—Disease—EP300—salivary gland cancer	0.000521	0.000521	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000507	0.000507	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—JAG1—salivary gland cancer	0.000495	0.000495	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGFR4—salivary gland cancer	0.000493	0.000493	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FOXO3—salivary gland cancer	0.000491	0.000491	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FBXW7—salivary gland cancer	0.000485	0.000485	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000475	0.000475	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NUP62—salivary gland cancer	0.000465	0.000465	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—VCAN—salivary gland cancer	0.000461	0.000461	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PTEN—salivary gland cancer	0.000458	0.000458	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.000441	0.000441	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAP2K2—salivary gland cancer	0.000439	0.000439	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—EP300—salivary gland cancer	0.000436	0.000436	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NOTCH1—salivary gland cancer	0.000421	0.000421	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FOXO3—salivary gland cancer	0.000409	0.000409	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000404	0.000404	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAP2K2—salivary gland cancer	0.000401	0.000401	CbGpPWpGaD
Raloxifene—AOX1—Disease—PIK3CA—salivary gland cancer	0.000385	0.000385	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—CREBBP—salivary gland cancer	0.000381	0.000381	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000375	0.000375	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOTCH1—salivary gland cancer	0.00036	0.00036	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.00036	0.00036	CbGpPWpGaD
Raloxifene—AOX1—Disease—HRAS—salivary gland cancer	0.000357	0.000357	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000346	0.000346	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAP2K2—salivary gland cancer	0.000334	0.000334	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CREBBP—salivary gland cancer	0.000331	0.000331	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000328	0.000328	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CREBBP—salivary gland cancer	0.000326	0.000326	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3CA—salivary gland cancer	0.000323	0.000323	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000314	0.000314	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000306	0.000306	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CREBBP—salivary gland cancer	0.000298	0.000298	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000289	0.000289	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.00028	0.00028	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000278	0.000278	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000275	0.000275	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOTCH1—salivary gland cancer	0.000274	0.000274	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HRAS—salivary gland cancer	0.000257	0.000257	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000254	0.000254	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000249	0.000249	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CREBBP—salivary gland cancer	0.000248	0.000248	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000247	0.000247	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCND1—salivary gland cancer	0.000241	0.000241	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PTEN—salivary gland cancer	0.000237	0.000237	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HRAS—salivary gland cancer	0.000235	0.000235	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTEN—salivary gland cancer	0.000233	0.000233	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—EP300—salivary gland cancer	0.000226	0.000226	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EP300—salivary gland cancer	0.000222	0.000222	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCND1—salivary gland cancer	0.00022	0.00022	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CREBBP—salivary gland cancer	0.000213	0.000213	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTEN—salivary gland cancer	0.000213	0.000213	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000204	0.000204	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EP300—salivary gland cancer	0.000203	0.000203	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCND1—salivary gland cancer	0.000184	0.000184	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CREBBP—salivary gland cancer	0.00018	0.00018	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTEN—salivary gland cancer	0.000177	0.000177	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EP300—salivary gland cancer	0.000169	0.000169	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CA—salivary gland cancer	0.000167	0.000167	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CA—salivary gland cancer	0.000164	0.000164	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—salivary gland cancer	0.000159	0.000159	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HRAS—salivary gland cancer	0.000152	0.000152	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PTEN—salivary gland cancer	0.000152	0.000152	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CA—salivary gland cancer	0.00015	0.00015	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—salivary gland cancer	0.000145	0.000145	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—EP300—salivary gland cancer	0.000145	0.000145	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HRAS—salivary gland cancer	0.000139	0.000139	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PTEN—salivary gland cancer	0.000129	0.000129	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CA—salivary gland cancer	0.000125	0.000125	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—EP300—salivary gland cancer	0.000123	0.000123	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—salivary gland cancer	0.000121	0.000121	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HRAS—salivary gland cancer	0.000116	0.000116	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CA—salivary gland cancer	0.000107	0.000107	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CREBBP—salivary gland cancer	9.67e-05	9.67e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CA—salivary gland cancer	9.08e-05	9.08e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PTEN—salivary gland cancer	6.9e-05	6.9e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—EP300—salivary gland cancer	6.58e-05	6.58e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	4.87e-05	4.87e-05	CbGpPWpGaD
